{
    "Trade/Device Name(s)": [
        "i-STAT PTplus Cartridge with the i-STAT 1 System"
    ],
    "Submitter Information": "Abbott Point of Care Inc.",
    "510(k) Number": "K220282",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071041"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS"
    ],
    "Summary Letter Date": "July 14, 2023",
    "Summary Letter Received Date": "February 1, 2022",
    "Submission Date": "January 28, 2022",
    "Regulation Number(s)": [
        "21 CFR 864.7750"
    ],
    "Regulation Name(s)": [
        "Prothrombin Time Test"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Prothrombin Time",
        "International Normalized Ratio (INR)"
    ],
    "Specimen Type(s)": [
        "Whole blood (venous)",
        "Whole blood (capillary)"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "i-STAT 1 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical technology",
        "Amperometric detection"
    ],
    "Methodologies": [
        "Quantitative measurement of clot time",
        "Electrochemical sensor"
    ],
    "Submission Type(s)": [
        "Cartridge",
        "Analyzer",
        "Control",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott i-STAT PTplus Cartridge with i-STAT 1 System for quantitative measurement of prothrombin time and INR in whole blood",
    "Indications for Use Summary": "Intended for in vitro quantitative measurement of the clot time of the extrinsic coagulation pathway activated by thromboplastin in non-anticoagulated whole blood (venous or capillary), aiding in monitoring patients receiving coumarin anticoagulant therapy with prothrombin time results reported in seconds and INR, for point of care and prescription use only",
    "fda_folder": "Hematology"
}